Tracheobronchial Stenting for Malignant Airway Disease: Long-Term Outcomes From a Single-Center Study. (November 2013)

• Record Type: Journal Article
• Authors: Inchingolo, Riccardo; Sabharwal, Tarun; Spiliopoulos, Stavros; Krokidis, Mitiadis; Dourado, Renato; Ahmed, Irfan; King, Juliet; Adam, Andreas
• Is Part Of: American journal of hospice & palliative care. Volume 30:Number 7(2013)
• Page Start: 683
• Page End: 689
• Publication Date: 2013-11
• Subjects: interventional radiology -- lung -- tracheobronchial tree -- stents -- fluoroscopy -- thorax; Hospice care -- Periodicals; Palliative treatment -- Periodicals; 362.175
• DOI: 10.1177/1049909112462861
• Languages: English
• ISSNs: 1049-9091

Abstract

The aim of this retrospective study is to investigate the immediate and long-term outcomes following the insertion of covered and uncovered self-expandable metallic stent (SEMS) for the management of malignant tracheobronchial disease. A total of 49 patients (27 male, mean age 60.9 ± 15 years) underwent 77 SEMS insertions (57 uncovered). The procedure was performed in theater using combined bronchoscopic and fluoroscopic guidance. The study's primary end points included technical success (97.9%), clinical success (91.8%), and symptom recurrence (14.2%). The mean follow-up time was 5.5 ± 5.9 months. We concluded that tracheobronchial SEMSs provide safe and effective minimally invasive long-term management of patients with symptomatic malignant airway disease.